CN1110565A - Anti-thristy melbine capsule and its production method - Google Patents

Anti-thristy melbine capsule and its production method Download PDF

Info

Publication number
CN1110565A
CN1110565A CN 94103531 CN94103531A CN1110565A CN 1110565 A CN1110565 A CN 1110565A CN 94103531 CN94103531 CN 94103531 CN 94103531 A CN94103531 A CN 94103531A CN 1110565 A CN1110565 A CN 1110565A
Authority
CN
China
Prior art keywords
rhizoma
powder
radix
capsule
thristy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN 94103531
Other languages
Chinese (zh)
Inventor
梁清吉
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN 94103531 priority Critical patent/CN1110565A/en
Publication of CN1110565A publication Critical patent/CN1110565A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The method for producing capsule for curing diabetes mellitus by effectively regulating metabolism and increasing immunity features use of trace elements along with Chinese-medicinal materials.

Description

Anti-thristy melbine capsule and its production method
The present invention relates to a kind of capsule and production method thereof for the treatment of diabetes.
At present, the oral diamicron of the general employing of treatment diabetes, glibenclamide tablet and transfusion filling insulin etc. are though play certain therapeutical effect to diabetics, but can not eradicate, diabetics generally shows as the dryness of the lung, gastric heat, suffer from a deficiency of the kidney, and the treatment still be limited to " control the person of disappearing, its lung of Yi Run; The person of disappearing in controlling, suitable clear its stomach; Control the inferior the person of disappearing, should grow its kidney " Chinese medicine that adopts is generally the Radix Astragali, the Radix Rehmanniae, pollen, Herba Dendrobii.Another symptom of diabetes is polydipsia, polyphagia, polyuria, loses weight, the initial stage patient Yin bivacuity that generally feels cold, scorching flourishing, the hepatic and renal YIN deficiency, the course of disease is than the elder and then numb hand and foot occurs, it is weak to become thin, dizzy cardiopalmus, visual deterioration or cataract occurs, retinopathy, menoxenia or amenorrhea, sexual impotence, just secrete or symptom such as diarrhoea, so diabetes are arch enemies of man, people are being devoted to seek a kind of effective pharmaceutical methods that effects a radical cure diabetes always, do not have the precedent of success so far.
Purpose of the present invention is exactly to adopt at the deficiency of existing treatment diabetes medicament and method:
The Chinese medicine that increases a large amount of blood circulation promoting and blood stasis dispelling, relaxing muscles and tendons and activating QI and blood in the collateral, the eliminating stagnation of regulating the flow of vital energy improves whole metabolic cycles, prevents the complication such as complex of blood stasis, sugar.
Mechanism of the present invention: according to modern medicine to physiology, pathological observation, 70-80% does not have the variation on the pathological anatomy in the diabetes human body, in many clinically cases, human body (comprising pancreatic tissue) inner blood viscosity increased, the appearance blood stasis that has, even generation thromboembolism phenomenon, in addition, contain sugar in diabetes patient's blood and increase, the complex that sugar can occur is deposited in the human capillary vessel, in the course of time, the people knows from experience, and the degeneration of cell fibrosis takes place, owing to be confined to the viewpoint of three types of diabetes, so the often merely difference of three types of diabetes in diagnosis and treatment, and when having ignored clearing away heat and nourishing YIN, add the product of helping blood circulation promoting and blood stasis dispelling.For this reason, long to the course of disease, long life has the patient of complication should increase blood circulation promoting and blood stasis dispelling, relaxing muscles and tendons and activating QI and blood in the collateral, the medicine of the eliminating stagnation of regulating the flow of vital energy, as, Radix Salviae Miltiorrhizae, Rhizoma Chuanxiong, Radix Ginseng etc., improve whole metabolic cycles, the complication such as complex that prevent blood stasis, thromboembolism and sugar occur, and could fundamentally reach the purpose of control and healing diabetes from integral body like this.
With addition of with the human body trace elements necessary.
We obtain important new progress to the research of trace element and diabetes; it is new problems that we propose that trace element can be prevented and treated diabetes; the new theory viewpoint; studies show that: micro elements needed by human ferrum; zinc; the metabolism of copper is relevant with diabetes; diabetes are pancreatic excreting insulin functional disorders and causing; the pancreatic surface is the film that is made of a large amount of multiple proteins; to protect and to keep the 26S Proteasome Structure and Function of pancreatic; the special albumen that trace element participates in the pancreatic surface synthesizes; this albumen is called " Glut-2 " protein; and " Glut-2 " protein can promote insulin secretion; glucose in the blood is delivered to the pancreas beta cell, thereby blood sugar content is descended.Discover: micro elements needed by human (Fe, Zn, Cu) be the conduction mediator of nervus centralis, its ion evenly distributes with strand and multichain form respectively systematically along nerve fiber in human body, contain a certain amount of trace element between the neuron, mitochondrion is prominent to be steeped etc., form the electron density district, it is regulated by the sympathetic nerve of nervus centralis and parasympathetic nervous that secretion of insulin is regulated, hypothalamus has the maincenter of regulating insulin secretion among the central nervous system, electricity irritation hypothalamus ventral lateral nucleus, insulin secretion is increased, for this reason, " anti-thristy melbine capsule " increases micro elements needed by human Fe, Zn, Cu.
Prescription of the present invention is (is unit of weight with the gram): Radix Astragali 16-24, pollen 16-24, Rhizoma Anemarrhenae 16-24, Herba Dendrobii 8-12, female ginseng 18-24, Rhizoma Chuanxiong 18-24, Rhizoma Coptidis 6-8.Fu Cen 6-8, Rhizoma Alismatis 6-9, Rhizoma Atractylodis Macrocephalae 8-12, Margarita powder 0.2-0.6, Colla Corii Asini powder 2-4, Radix Rehmanniae 8-12, Radix Ginseng 6-8, Rhizoma Pinelliae 6-8, the trace element of adding is (is unit of weight with the milligram) zinc sulfate 260-340, ferrous sulfate 550-650, copper sulfate 45-55.
Technology of the present invention is:
1, with the Radix Astragali, pollen, the Rhizoma Anemarrhenae, Herba Dendrobii, female ginseng, Rhizoma Chuanxiong, Rhizoma Coptidis, Poria, Rhizoma Alismatis, the Rhizoma Atractylodis Macrocephalae, the Radix Rehmanniae take by weighing by proportioning and mix, under 35-42 ℃ of condition, use distilled water extraction, extracting solution is distilled under 95-100 ℃ of condition, with the ethanol precipitate with ethanol of distillate with 85-95%, remove ethanol then, the liquid of this moment is the runny plaste shape, and then drying is made dried cream about 110 ℃, dried cream powder is broken and in 80 mesh sieves screenings, and be powder A this moment;
2, Radix Ginseng, Colla Corii Asini, Margarita, the Rhizoma Pinelliae, zinc sulfate, ferrous sulfate, copper sulfate are pulverized 80 mesh sieves, made dry powder B;
3, powder A and dry powder B are mixed adding starch, adjuvants such as Pulvis Talci stir, and are finished product, with the finished product packing, make capsule.
Embodiments of the invention see Table, and mark all is not unit with g:
Real
Become to execute 123
Part example
The Radix Astragali 16 20 24
Pollen 16 20 24
The Rhizoma Anemarrhenae 16 20 24
Herba Dendrobii 8 10 12
Radix Salviae Miltiorrhizae 18 21 24
Rhizoma Chuanxiong 18 21 24
Rhizoma Coptidis 678
Fu Cen 678
Rhizoma Alismatis 678
The Rhizoma Atractylodis Macrocephalae 8 10 12
Margarita 0.2 0.4 0.6
Colla Corii Asini powder 234
The Radix Rehmanniae 8 10 12
Radix Ginseng 678
The Rhizoma Pinelliae 678
Zinc sulfate (mg) 260 300 340
Ferrous sulfate (mg) 550 600 650
Copper sulfate (mg) 45 50 55
Present embodiment technology is the same.
The present invention can regulate the metabolic function of human body effectively, improves autoimmunity, and this medical instrument has: the function of promoting the production of body fluid to quench thirst, clearing heat and moistening dryness, replenishing QI to invigorate the spleen, enriching yin and nourishing kidney, blood circulation promoting and blood stasis dispelling.Example is observed surplus clinical 3000, and effective percentage reaches 82%.

Claims (2)

1, a kind of anti-thristy melbine capsule, its prescription is (mark is not a unit with the gram): Radix Astragali 16-24, pollen 16-24, Rhizoma Anemarrhenae 16-24, Herba Dendrobii 8-12, female ginseng 18-24, Rhizoma Chuanxiong 18-24, Rhizoma Coptidis 6-8, Poria 6-8, Rhizoma Alismatis 6-9, Rhizoma Atractylodis Macrocephalae 8-12, Margarita powder 0.2-0.6, Colla Corii Asini powder 2-4, Radix Rehmanniae 8-12, Radix Ginseng 6-8, Rhizoma Pinelliae 6-8, the trace element that adds is (is unit of weight with the milligram) zinc sulfate 260-340, ferrous sulfate 550-650, copper sulfate 45-55.
2, the anti-thristy melbine capsule production method is with the Radix Astragali, pollen, the Rhizoma Anemarrhenae, Herba Dendrobii, female ginseng, Rhizoma Chuanxiong, Rhizoma Coptidis, Poria, Rhizoma Alismatis, the Rhizoma Atractylodis Macrocephalae, the Radix Rehmanniae take by weighing by proportioning and mix, under 35-42 ℃ of condition, use distilled water extraction, extracting solution is distilled under 95-100 ℃ of condition, with the ethanol precipitate with ethanol of distillate with 85-95%, remove ethanol then, the liquid of this moment is the runny plaste shape, and then drying is made dried cream about 110 ℃, dried cream powder is broken and in 80 mesh sieves screenings, and be powder A this moment;
Radix Ginseng, Colla Corii Asini, Margarita, the Rhizoma Pinelliae, zinc sulfate, ferrous sulfate, copper sulfate are pulverized 80 mesh sieves, made dry powder B;
Powder A and dry powder B are mixed adding starch, and adjuvants such as Pulvis Talci stir, and are finished product, with the finished product packing, make capsule.
CN 94103531 1994-04-21 1994-04-21 Anti-thristy melbine capsule and its production method Pending CN1110565A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN 94103531 CN1110565A (en) 1994-04-21 1994-04-21 Anti-thristy melbine capsule and its production method

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN 94103531 CN1110565A (en) 1994-04-21 1994-04-21 Anti-thristy melbine capsule and its production method

Publications (1)

Publication Number Publication Date
CN1110565A true CN1110565A (en) 1995-10-25

Family

ID=5031136

Family Applications (1)

Application Number Title Priority Date Filing Date
CN 94103531 Pending CN1110565A (en) 1994-04-21 1994-04-21 Anti-thristy melbine capsule and its production method

Country Status (1)

Country Link
CN (1) CN1110565A (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1052386C (en) * 1997-05-23 2000-05-17 尤新 Functional food for lowering blood-sugar, blood-lipid and blood-presure
CN1114421C (en) * 2000-04-29 2003-07-16 杨俊华 Chinese medicine for treating diabetes
CN104940638A (en) * 2015-05-26 2015-09-30 霍山县淮源农业科技发展有限公司 Traditional Chinese medicine combined decoction for treating diabetes and preparation method of traditional Chinese medicine combined decoction

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1052386C (en) * 1997-05-23 2000-05-17 尤新 Functional food for lowering blood-sugar, blood-lipid and blood-presure
CN1114421C (en) * 2000-04-29 2003-07-16 杨俊华 Chinese medicine for treating diabetes
CN104940638A (en) * 2015-05-26 2015-09-30 霍山县淮源农业科技发展有限公司 Traditional Chinese medicine combined decoction for treating diabetes and preparation method of traditional Chinese medicine combined decoction

Similar Documents

Publication Publication Date Title
CN1305844A (en) Medicine for treating congestive heart failure
CN1876150A (en) A medicinal liquor for treating spleen deficiency type chronic diarrhea and preparation method thereof
CN101690789B (en) Chinese medicinal preparation for treating diabetes
CN1091027A (en) Blood-pressure reducing plaster sticking on acupoint and preparation method thereof
CN1110565A (en) Anti-thristy melbine capsule and its production method
CN1879825A (en) A medicinal liquor for treating lower jiao heat accumulation type hematuria and method for preparing same
CN101549057A (en) Chinese medicine composition for curing hyperlipemia, cerebral arteriosclerosis and ischemic apoplexy and method of preparing the same
CN1911318A (en) Decoction of herbal medicine for treating insufficiency of both the spleen and the kidney type aplastic anemia, and its prepn. method
CN1075727C (en) Shentong capsule and preparing method thereof
CN1319586C (en) Medicinal composition for treating brain apoplexy
CN1053111C (en) Chinese medical composite preparation with such functions as dispelling toxicity, detoxicating, recuperating, health preserving and face nursing
CN1895504A (en) Chinese medicine for treating osteoporosis and its preparation
CN1169564C (en) New medicine for curing diobetes
CN1263488C (en) Capsule of dual gen-sengs and preparing technique
CN1695715A (en) Medication for treating dementia in blood vessel type, and preparation method
CN101239149A (en) Orally-taken Chinese medicinal composition for treating diabetes
CN1282475C (en) Combination of medication for treating gallbladder disease and preparation method
CN110215474B (en) Traditional Chinese medicine composition for promoting blood circulation to remove blood stasis and application thereof
CN1911363A (en) Decoction for treating deficiency of live-yin and kidney-yin type aplastic anemia, and its prepn. method
CN1101213C (en) Diabetes treating medicine
CN1054525C (en) Medicinal composition for treating diabetes involving lower jiao
CN1915348A (en) Medication of medical broth for treating congestion type condyloma acuminatum, and preparation method
CN102225132A (en) Traditional Chinese medicine compound for treating hyperlipidaemia, cerebral arteriosclerosis and ischemic stroke and preparation method thereof
CN1363386A (en) Composition Chinese-medicinal herb pieces and preparing process thereof
CN100998683A (en) Process for preparing granule of radix rehmanniae and radix achyranthis bidentatae

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C01 Deemed withdrawal of patent application (patent law 1993)
WD01 Invention patent application deemed withdrawn after publication